经眶超声显示治疗后的巨细胞动脉炎患者视网膜动脉血流及视神经直径持续下降
这项前瞻性队列研究对36例新诊断巨细胞动脉炎(GCA)患者每3个月进行经眶超声(TOS)评估视网膜中央动脉血流速度和视神经直径(OND),随访12个月。结果显示治疗后视网膜动脉血流和OND持续下降,提示尽管临床改善,视网膜血管供应仍在受损并可能出现视神经萎缩。
要点
- 新诊断GCA患者36例,基线时17例(47.2%)有视觉症状,随访12个月。
- 与基线相比,收缩期峰值流速(PSV)在3个月和9个月显著下降,OND在3个月和12个月显著下降。
- 有视觉症状的眼在病程中PSV和EDV显著更高,基线异常血管数和OGUS评分与血流负相关、与OND正相关。
核心结论
- 经眶超声显示GCA患者治疗后视网膜动脉血流和OND进行性下降,提示视网膜血管供应持续受损并可能出现视神经萎缩。
- 作者认为GCA的颅内血管改变对治疗的反应可能不如颅外血管有效,并支持GCA存在共同的病理生理机制。
研究设计与样本
- 前瞻性队列研究,纳入新诊断GCA患者36例,每3个月进行经眶超声评估视网膜中央动脉血流速度(PSV、EDV、RI)和OND,随访12个月,同时进行血管超声并计算OMERACT巨细胞动脉炎超声(OGUS)评分。
- 采用线性混合效应模型分析纵向变化及关联,考虑患者内重复测量。
主要发现
- 基线时17例(47.2%)患者报告视觉症状。
- 与基线相比,PSV在3个月(β = -0.81 cm/s,P = 0.046)和9个月(β = -0.93 cm/s,P = 0.029)显著下降。
- OND在3个月(β = -0.30 mm,P = 0.020)和12个月(β = -0.35 mm,P = 0.008)下降,随访期间呈一致趋势(β = -0.07,P = 0.024)。
- 有视觉症状的眼在病程中PSV(β = 0.96,P = 0.017)和EDV(β = 0.34,P = 0.037)显著更高。
- 基线异常血管数和OGUS评分与PSV(β = -0.43,P = 0.031;β = -3.15,P = 0.055)和EDV(β = -0.15,P = 0.022;β = -1.45,P = 0.007)负相关,与OND(β = 0.15,P = 0.006;β = 0.94,P = 0.040)正相关;病程中异常血管数和OGUS评分与EDV(β = -0.04,P = 0.024;β = -0.77,P = 0.005)和OND(β = 0.05,P < 0.001;β = 0.72,P < 0.001)显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To longitudinally assess ocular involvement in newly diagnosed giant cell arteritis (GCA) patients by evaluating changes in transorbital ultrasonography (TOS) parameters and their association with systemic vascular inflammation and treatment response. METHODS: In this prospective cohort study, newly diagnosed GCA patients underwent serial TOS assessments of the central retinal artery flow velocity [peak systolic velocity (PSV), end-diastolic velocity (EDV), resistance index (RI)] and optic nerve diameter (OND) at three-monthly intervals for 12 months. Vascular ultrasonography and calculation of OMERACT Giant Cell Arteritis Ultrasonography (OGUS) Score was conducted. Longitudinal changes and associations were analysed using linear mixed-effects models, accounting for repeated measurements within patients. RESULTS: Thirty-six GCA patients were enrolled. At baseline, 17 (47.2%) patients reported visual symptoms. Compared with baseline, PSV significantly decreased at three (β = -0.81 cm/s, P = 0.046) and nine (β = -0.93 cm/s, P = 0.029) months. OND decreased at three (β = -0.30 mm, P = 0.020) and 12 (β = -0.35 mm, P = 0.008) months, with a consistent trend over follow-up (β = -0.07, P = 0.024). Symptomatic eyes displayed significantly higher PSV (β = 0.96, P = 0.017) and EDV (β = 0.34, P = 0.037) over disease course. Baseline pathological vessel count and OGUS Score were negatively associated with PSV (β = -0.43, P = 0.031; β = -3.15, P = 0.055) and EDV (β = -0.15, P = 0.022; β = -1.45, P = 0.007) and positively associated with OND (β = 0.15, P = 0.006; β = 0.94, P = 0.040). During disease course, significant associations with pathological vessel count and OGUS Score were noted for EDV (β = -0.04, P = 0.024; β = -0.77, P = 0.005) and OND (β = 0.05, P < 0.001; β = 0.72, P < 0.001). CONCLUSIONS: Utilizing TOS, we demonstrated progressive decrease in retinal artery flow and OND, indicating ongoing impairment in retinal vascular supply and potential optic nerve atrophy despite clinical improvement post-treatment. Our findings suggest that intracranial vascular changes in GCA may respond less effectively to treatment than extracranial vessels and support a shared pathophysiological mechanism in GCA.
引用
- Petzinna SM, Burg LC, Terheyden JH, et al. Transorbital ultrasonography reveals persistent decrease in retinal artery flow and optic nerve diameter in treated giant cell arteritis. Rheumatology (Oxford). 2026. PMID: 40880298. doi:10.1093/rheumatology/keaf456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。